current — rebuilt 7m ago
Accelerate precision diagnostics and medicine for women's health observed
No person- or entity-level identity check is on record for this company. A name match is not one.
The inclusion bar: two or more independent sourced evidence families. This profile is published and listed. It is a statement about how much evidence we hold, and about nothing else.
Evidence places this company outside this buyer’s market. The profile stays published; this labels it.
POSITIVE MANDATE MISMATCH: the latest covered financing event carries a source-stated stage of series_b, beyond the frozen seed/Series-A mandate. Latest round resolved by the projection is series_b; no unlabelled event (e.g. a later Form D) is held that could supersede it. OVERTURN CONDITION: a source showing the latest financing event is actually seed/Series-A, or that the buyer mandate includes series_b. The verdict rests on the SOURCE-STATED stage "series_b", not on size, age or industry.
What would overturn this:
Assessed 2026-10-24 for seed/Series-A sourcing.
Five evidence lanes (activity, capital, infra, hiring, ecosystem) as within-cohort percentiles, combined with evidence-breadth weights over the 60-company baseline cohort. The ± band widens with missing lanes — it measures what the score stands on. 3 signals in the last 60 days back this number.
↗ Strongest signal: funding_recency (18% of the score).
↓ Scored on 2 of 4 components — adoption, developer had no computable metric.
No single number decides. Layers can disagree — that's the point. New to this? →
VentureSignalScore 52.4/100 for evvy, composed from 2 of 4 components (emerging formula), discounted ×0.85 for 50% signal coverage
| Component | Weight | Normalized | Contribution |
|---|---|---|---|
| funding_recency | 0.2 | 0.8812 | |
| funding_magnitude | 0.3 | 0.4408 |
funding.round.announced_on 2026-09-15 artifact ↗ funding.round.amount_usd 2026-09-15 artifact ↗ An evidence gap, not proof of falsity: Form D is not always required (foreign offerings, certain exemptions) or may not be filed yet.
A first sale, a filing, an amendment and a public announcement are not the same event, and one date may not stand in for another. Where the latest financing date cannot be established from what we hold, this says unknown rather than substituting a date we do have.
A reported round dated 2026-09-15 by its own source.
| Attribute | Value | Kind | Source | Observed | State | Conf. |
|---|---|---|---|---|---|---|
buyer_fit.assessment | {"buyer": "seed/Series-A sourcing", "method": "Backlog pass 2026-10-24: applied the record_buyer_fit.ts fit rule to this company's held primary-source financing evidence (funding.round.* / sec.form_d. | observed | assessment | 2026-10-24 | normalized | 0.90 |
buyer_fit.status | not_a_fit | observed | assessment | 2026-10-24 | normalized | 0.90 |
common_name | Evvy | observed | artifact ↗ | 2026-09-28 | normalized | 0.90 |
community.hn.max_points | 314 | observed | artifact ↗ | 2026-09-30 | superseded | 0.20 |
community.hn.max_points | 0 | observed | artifact ↗ | 2026-10-08 | normalized | 0.20 |
community.hn.mentions | 50 | observed | artifact ↗ | 2026-09-30 | superseded | 0.20 |
community.hn.mentions | 0 | observed | artifact ↗ | 2026-10-08 | normalized | 0.20 |
community.hn.rumors | [] | observed | artifact ↗ | 2026-09-30 | normalized | 0.20 |
community.hn.top_story | {"url": "https://news.ycombinator.com/item?id=20433301", "title": "Ask HN: How do you deal with professional envy?", "points": 314, "created_at": "2019-07-14"} | observed | artifact ↗ | 2019-07-14 | superseded | 0.20 |
community.hn.top_story | {} | observed | artifact ↗ | 2026-10-08 | normalized | 0.20 |
description | Accelerate precision diagnostics and medicine for women's health | observed | derived | 2026-10-01 | normalized | 0.60 |
funding.round.amount_usd | 40000000 | observed | artifact ↗ | 2026-09-15 | normalized | 0.90 |
funding.round.announced_on | 2026-09-15 | observed | artifact ↗ | 2026-09-15 | normalized | 0.90 |
funding.round.lead_investors | ["Catalio Capital Management"] | observed | artifact ↗ | 2026-09-15 | normalized | 0.90 |
funding.round.source_url | https://siliconangle.com/2026/09/15/ai-startup-evvy-raises-40m-to-accelerate-precision-diagnostics-and-medicine-for-womens-health/ | observed | artifact ↗ | 2026-09-15 | normalized | 0.90 |
funding.round.stage | series_b | observed | artifact ↗ | 2026-09-15 | normalized | 0.90 |
metric.venture.funding_amount_usd | 40000000 | derived | calc | 2026-09-28 | derived | 0.90 |
metric.venture.funding_recency_days | 13.9753 | derived | calc | 2026-09-28 | superseded | 0.90 |
metric.venture.funding_recency_days | 15.6507 | derived | calc | 2026-09-30 | superseded | 0.90 |
metric.venture.funding_recency_days | 15.7072 | derived | calc | 2026-09-30 | superseded | 0.90 |
metric.venture.funding_recency_days | 16.344 | derived | calc | 2026-10-01 | superseded | 0.90 |
metric.venture.funding_recency_days | 16.3827 | derived | calc | 2026-10-01 | superseded | 0.90 |
metric.venture.funding_recency_days | 16.4726 | derived | calc | 2026-10-01 | superseded | 0.90 |
metric.venture.funding_recency_days | 16.6283 | derived | calc | 2026-10-01 | superseded | 0.90 |
metric.venture.funding_recency_days | 16.719 | derived | calc | 2026-10-01 | superseded | 0.90 |
metric.venture.funding_recency_days | 16.7445 | derived | calc | 2026-10-01 | superseded | 0.90 |
metric.venture.funding_recency_days | 16.786 | derived | calc | 2026-10-01 | superseded | 0.90 |
metric.venture.funding_recency_days | 23.8891 | derived | calc | 2026-10-08 | superseded | 0.90 |
metric.venture.funding_recency_days | 24.3089 | derived | calc | 2026-10-09 | superseded | 0.90 |
metric.venture.funding_recency_days | 24.56 | derived | calc | 2026-10-09 | superseded | 0.90 |
metric.venture.funding_recency_days | 24.8514 | derived | calc | 2026-10-09 | superseded | 0.90 |
metric.venture.funding_recency_days | 24.9519 | derived | calc | 2026-10-09 | superseded | 0.90 |
metric.venture.funding_recency_days | 25.126 | derived | calc | 2026-10-10 | superseded | 0.90 |
metric.venture.funding_recency_days | 25.1268 | derived | calc | 2026-10-10 | superseded | 0.90 |
metric.venture.funding_recency_days | 25.214 | derived | calc | 2026-10-10 | superseded | 0.90 |
metric.venture.funding_recency_days | 25.3077 | derived | calc | 2026-10-10 | superseded | 0.90 |
metric.venture.funding_recency_days | 25.419 | derived | calc | 2026-10-10 | superseded | 0.90 |
metric.venture.funding_recency_days | 25.5125 | derived | calc | 2026-10-10 | superseded | 0.90 |
metric.venture.funding_recency_days | 25.6039 | derived | calc | 2026-10-10 | superseded | 0.90 |
metric.venture.funding_recency_days | 25.6913 | derived | calc | 2026-10-10 | superseded | 0.90 |
metric.venture.funding_recency_days | 25.7801 | derived | calc | 2026-10-10 | superseded | 0.90 |
metric.venture.funding_recency_days | 25.8343 | derived | calc | 2026-10-10 | superseded | 0.90 |
metric.venture.funding_recency_days | 25.9221 | derived | calc | 2026-10-10 | superseded | 0.90 |
metric.venture.funding_recency_days | 26.0218 | derived | calc | 2026-10-11 | superseded | 0.90 |
metric.venture.funding_recency_days | 26.1081 | derived | calc | 2026-10-11 | superseded | 0.90 |
metric.venture.funding_recency_days | 26.1086 | derived | calc | 2026-10-11 | superseded | 0.90 |
metric.venture.funding_recency_days | 26.1403 | derived | calc | 2026-10-11 | superseded | 0.90 |
metric.venture.funding_recency_days | 26.2221 | derived | calc | 2026-10-11 | superseded | 0.90 |
metric.venture.funding_recency_days | 26.3229 | derived | calc | 2026-10-11 | superseded | 0.90 |
metric.venture.funding_recency_days | 26.3787 | derived | calc | 2026-10-11 | superseded | 0.90 |
metric.venture.funding_recency_days | 26.4189 | derived | calc | 2026-10-11 | superseded | 0.90 |
metric.venture.funding_recency_days | 26.5083 | derived | calc | 2026-10-11 | superseded | 0.90 |
metric.venture.funding_recency_days | 26.5981 | derived | calc | 2026-10-11 | superseded | 0.90 |
metric.venture.funding_recency_days | 26.6875 | derived | calc | 2026-10-11 | superseded | 0.90 |
metric.venture.funding_recency_days | 26.7777 | derived | calc | 2026-10-11 | superseded | 0.90 |
metric.venture.funding_recency_days | 26.8695 | derived | calc | 2026-10-11 | superseded | 0.90 |
metric.venture.funding_recency_days | 26.959 | derived | calc | 2026-10-11 | superseded | 0.90 |
metric.venture.funding_recency_days | 27.0402 | derived | calc | 2026-10-12 | superseded | 0.90 |
metric.venture.funding_recency_days | 27.0935 | derived | calc | 2026-10-12 | superseded | 0.90 |
metric.venture.funding_recency_days | 27.1364 | derived | calc | 2026-10-12 | superseded | 0.90 |
metric.venture.funding_recency_days | 27.2083 | derived | calc | 2026-10-12 | superseded | 0.90 |
metric.venture.funding_recency_days | 27.9933 | derived | calc | 2026-10-12 | superseded | 0.90 |
metric.venture.funding_recency_days | 28.0415 | derived | calc | 2026-10-13 | superseded | 0.90 |
metric.venture.funding_recency_days | 28.0948 | derived | calc | 2026-10-13 | superseded | 0.90 |
metric.venture.funding_recency_days | 28.2743 | derived | calc | 2026-10-13 | superseded | 0.90 |
metric.venture.funding_recency_days | 29.3782 | derived | calc | 2026-10-14 | superseded | 0.90 |
metric.venture.funding_recency_days | 29.4705 | derived | calc | 2026-10-14 | superseded | 0.90 |
metric.venture.funding_recency_days | 29.58 | derived | calc | 2026-10-14 | superseded | 0.90 |
metric.venture.funding_recency_days | 29.675 | derived | calc | 2026-10-14 | superseded | 0.90 |
metric.venture.funding_recency_days | 29.7722 | derived | calc | 2026-10-14 | superseded | 0.90 |
metric.venture.funding_recency_days | 29.8673 | derived | calc | 2026-10-14 | superseded | 0.90 |
metric.venture.funding_recency_days | 29.9626 | derived | calc | 2026-10-14 | superseded | 0.90 |
metric.venture.funding_recency_days | 30.0597 | derived | calc | 2026-10-15 | superseded | 0.90 |
metric.venture.funding_recency_days | 30.1548 | derived | calc | 2026-10-15 | superseded | 0.90 |
metric.venture.funding_recency_days | 30.311 | derived | calc | 2026-10-15 | superseded | 0.90 |
metric.venture.funding_recency_days | 30.4065 | derived | calc | 2026-10-15 | superseded | 0.90 |
metric.venture.funding_recency_days | 30.5073 | derived | calc | 2026-10-15 | superseded | 0.90 |
metric.venture.funding_recency_days | 30.6149 | derived | calc | 2026-10-15 | superseded | 0.90 |
metric.venture.funding_recency_days | 30.7105 | derived | calc | 2026-10-15 | superseded | 0.90 |
metric.venture.funding_recency_days | 30.8091 | derived | calc | 2026-10-15 | superseded | 0.90 |
metric.venture.funding_recency_days | 30.9051 | derived | calc | 2026-10-15 | superseded | 0.90 |
metric.venture.funding_recency_days | 31.0033 | derived | calc | 2026-10-16 | superseded | 0.90 |
metric.venture.funding_recency_days | 31.0994 | derived | calc | 2026-10-16 | superseded | 0.90 |
metric.venture.funding_recency_days | 31.1957 | derived | calc | 2026-10-16 | superseded | 0.90 |
metric.venture.funding_recency_days | 31.2945 | derived | calc | 2026-10-16 | superseded | 0.90 |
metric.venture.funding_recency_days | 31.3917 | derived | calc | 2026-10-16 | superseded | 0.90 |
metric.venture.funding_recency_days | 31.4879 | derived | calc | 2026-10-16 | superseded | 0.90 |
metric.venture.funding_recency_days | 31.4885 | derived | calc | 2026-10-16 | superseded | 0.90 |
metric.venture.funding_recency_days | 31.5873 | derived | calc | 2026-10-16 | superseded | 0.90 |
metric.venture.funding_recency_days | 33.5115 | derived | calc | 2026-10-18 | superseded | 0.90 |
metric.venture.funding_recency_days | 33.6092 | derived | calc | 2026-10-18 | superseded | 0.90 |
metric.venture.funding_recency_days | 33.7064 | derived | calc | 2026-10-18 | superseded | 0.90 |
metric.venture.funding_recency_days | 34.096 | derived | calc | 2026-10-19 | superseded | 0.90 |
metric.venture.funding_recency_days | 34.1928 | derived | calc | 2026-10-19 | superseded | 0.90 |
metric.venture.funding_recency_days | 34.2952 | derived | calc | 2026-10-19 | superseded | 0.90 |
metric.venture.funding_recency_days | 34.3975 | derived | calc | 2026-10-19 | superseded | 0.90 |
metric.venture.funding_recency_days | 34.4952 | derived | calc | 2026-10-19 | superseded | 0.90 |
metric.venture.funding_recency_days | 34.6095 | derived | calc | 2026-10-19 | superseded | 0.90 |
metric.venture.funding_recency_days | 34.7065 | derived | calc | 2026-10-19 | superseded | 0.90 |
metric.venture.funding_recency_days | 34.7068 | derived | calc | 2026-10-19 | superseded | 0.90 |
metric.venture.funding_recency_days | 34.8039 | derived | calc | 2026-10-19 | superseded | 0.90 |
metric.venture.funding_recency_days | 34.901 | derived | calc | 2026-10-19 | superseded | 0.90 |
metric.venture.funding_recency_days | 34.9983 | derived | calc | 2026-10-19 | superseded | 0.90 |
metric.venture.funding_recency_days | 35.1293 | derived | calc | 2026-10-20 | superseded | 0.90 |
metric.venture.funding_recency_days | 35.2289 | derived | calc | 2026-10-20 | superseded | 0.90 |
metric.venture.funding_recency_days | 35.3291 | derived | calc | 2026-10-20 | superseded | 0.90 |
metric.venture.funding_recency_days | 35.4304 | derived | calc | 2026-10-20 | superseded | 0.90 |
metric.venture.funding_recency_days | 35.5458 | derived | calc | 2026-10-20 | superseded | 0.90 |
metric.venture.funding_recency_days | 35.9993 | derived | calc | 2026-10-20 | superseded | 0.90 |
metric.venture.funding_recency_days | 36.0637 | derived | calc | 2026-10-21 | superseded | 0.90 |
metric.venture.funding_recency_days | 36.1614 | derived | calc | 2026-10-21 | superseded | 0.90 |
metric.venture.funding_recency_days | 36.2559 | derived | calc | 2026-10-21 | superseded | 0.90 |
metric.venture.funding_recency_days | 36.3257 | derived | calc | 2026-10-21 | superseded | 0.90 |
metric.venture.funding_recency_days | 36.4286 | derived | calc | 2026-10-21 | superseded | 0.90 |
metric.venture.funding_recency_days | 36.5331 | derived | calc | 2026-10-21 | superseded | 0.90 |
metric.venture.funding_recency_days | 36.6318 | derived | calc | 2026-10-21 | superseded | 0.90 |
metric.venture.funding_recency_days | 36.7312 | derived | calc | 2026-10-21 | superseded | 0.90 |
metric.venture.funding_recency_days | 36.8301 | derived | calc | 2026-10-21 | superseded | 0.90 |
metric.venture.funding_recency_days | 36.9285 | derived | calc | 2026-10-21 | superseded | 0.90 |
metric.venture.funding_recency_days | 36.929 | derived | calc | 2026-10-21 | superseded | 0.90 |
metric.venture.funding_recency_days | 37.0361 | derived | calc | 2026-10-22 | superseded | 0.90 |
metric.venture.funding_recency_days | 37.1352 | derived | calc | 2026-10-22 | superseded | 0.90 |
metric.venture.funding_recency_days | 37.2343 | derived | calc | 2026-10-22 | superseded | 0.90 |
metric.venture.funding_recency_days | 37.3359 | derived | calc | 2026-10-22 | superseded | 0.90 |
metric.venture.funding_recency_days | 37.4352 | derived | calc | 2026-10-22 | superseded | 0.90 |
metric.venture.funding_recency_days | 37.5524 | derived | calc | 2026-10-22 | superseded | 0.90 |
metric.venture.funding_recency_days | 37.6519 | derived | calc | 2026-10-22 | superseded | 0.90 |
metric.venture.funding_recency_days | 37.7516 | derived | calc | 2026-10-22 | superseded | 0.90 |
metric.venture.funding_recency_days | 37.8549 | derived | calc | 2026-10-22 | superseded | 0.90 |
metric.venture.funding_recency_days | 37.9541 | derived | calc | 2026-10-22 | superseded | 0.90 |
metric.venture.funding_recency_days | 38.0547 | derived | calc | 2026-10-23 | superseded | 0.90 |
metric.venture.funding_recency_days | 38.1545 | derived | calc | 2026-10-23 | superseded | 0.90 |
metric.venture.funding_recency_days | 38.2547 | derived | calc | 2026-10-23 | superseded | 0.90 |
metric.venture.funding_recency_days | 38.3741 | derived | calc | 2026-10-23 | superseded | 0.90 |
metric.venture.funding_recency_days | 38.4744 | derived | calc | 2026-10-23 | superseded | 0.90 |
metric.venture.funding_recency_days | 38.5804 | derived | calc | 2026-10-23 | superseded | 0.90 |
metric.venture.funding_recency_days | 38.6807 | derived | calc | 2026-10-23 | superseded | 0.90 |
metric.venture.funding_recency_days | 38.8148 | derived | calc | 2026-10-23 | superseded | 0.90 |
metric.venture.funding_recency_days | 38.8811 | derived | calc | 2026-10-23 | superseded | 0.90 |
metric.venture.funding_recency_days | 38.9813 | derived | calc | 2026-10-23 | superseded | 0.90 |
metric.venture.funding_recency_days | 39.0714 | derived | calc | 2026-10-24 | superseded | 0.90 |
metric.venture.funding_recency_days | 39.1279 | derived | calc | 2026-10-24 | superseded | 0.90 |
metric.venture.funding_recency_days | 39.1722 | derived | calc | 2026-10-24 | superseded | 0.90 |
metric.venture.funding_recency_days | 39.2631 | derived | calc | 2026-10-24 | superseded | 0.90 |
metric.venture.funding_recency_days | 39.4505 | derived | calc | 2026-10-24 | superseded | 0.90 |
metric.venture.funding_recency_days | 39.562 | derived | calc | 2026-10-24 | superseded | 0.90 |
metric.venture.funding_recency_days | 39.6629 | derived | calc | 2026-10-24 | superseded | 0.90 |
metric.venture.funding_recency_days | 39.7641 | derived | calc | 2026-10-24 | superseded | 0.90 |
metric.venture.funding_recency_days | 39.8652 | derived | calc | 2026-10-24 | superseded | 0.90 |
metric.venture.funding_recency_days | 39.9664 | derived | calc | 2026-10-24 | superseded | 0.90 |
metric.venture.funding_recency_days | 40.0673 | derived | calc | 2026-10-25 | superseded | 0.90 |
metric.venture.funding_recency_days | 40.1691 | derived | calc | 2026-10-25 | superseded | 0.90 |
metric.venture.funding_recency_days | 40.271 | derived | calc | 2026-10-25 | superseded | 0.90 |
metric.venture.funding_recency_days | 40.3723 | derived | calc | 2026-10-25 | superseded | 0.90 |
metric.venture.funding_recency_days | 40.4743 | derived | calc | 2026-10-25 | superseded | 0.90 |
metric.venture.funding_recency_days | 40.5781 | derived | calc | 2026-10-25 | superseded | 0.90 |
metric.venture.funding_recency_days | 40.6797 | derived | calc | 2026-10-25 | superseded | 0.90 |
metric.venture.funding_recency_days | 40.7814 | derived | calc | 2026-10-25 | superseded | 0.90 |
metric.venture.funding_recency_days | 40.8831 | derived | calc | 2026-10-25 | superseded | 0.90 |
metric.venture.funding_recency_days | 40.9853 | derived | calc | 2026-10-25 | superseded | 0.90 |
metric.venture.funding_recency_days | 41.0873 | derived | calc | 2026-10-26 | superseded | 0.90 |
metric.venture.funding_recency_days | 41.1887 | derived | calc | 2026-10-26 | superseded | 0.90 |
metric.venture.funding_recency_days | 41.2915 | derived | calc | 2026-10-26 | superseded | 0.90 |
metric.venture.funding_recency_days | 41.3935 | derived | calc | 2026-10-26 | superseded | 0.90 |
metric.venture.funding_recency_days | 41.4966 | derived | calc | 2026-10-26 | superseded | 0.90 |
metric.venture.funding_recency_days | 41.6081 | derived | calc | 2026-10-26 | superseded | 0.90 |
metric.venture.funding_recency_days | 41.7105 | derived | calc | 2026-10-26 | superseded | 0.90 |
metric.venture.funding_recency_days | 41.8134 | derived | calc | 2026-10-26 | superseded | 0.90 |
metric.venture.funding_recency_days | 41.916 | derived | calc | 2026-10-26 | superseded | 0.90 |
metric.venture.funding_recency_days | 42.0186 | derived | calc | 2026-10-27 | superseded | 0.90 |
metric.venture.funding_recency_days | 42.2231 | derived | calc | 2026-10-27 | superseded | 0.90 |
metric.venture.funding_recency_days | 42.3283 | derived | calc | 2026-10-27 | superseded | 0.90 |
metric.venture.funding_recency_days | 42.4309 | derived | calc | 2026-10-27 | superseded | 0.90 |
metric.venture.funding_recency_days | 42.5413 | derived | calc | 2026-10-27 | superseded | 0.90 |
metric.venture.funding_recency_days | 42.6442 | derived | calc | 2026-10-27 | superseded | 0.90 |
metric.venture.funding_recency_days | 42.7474 | derived | calc | 2026-10-27 | superseded | 0.90 |
metric.venture.funding_recency_days | 42.8505 | derived | calc | 2026-10-27 | superseded | 0.90 |
metric.venture.funding_recency_days | 42.9535 | derived | calc | 2026-10-27 | superseded | 0.90 |
metric.venture.funding_recency_days | 43.0567 | derived | calc | 2026-10-28 | superseded | 0.90 |
metric.venture.funding_recency_days | 43.1599 | derived | calc | 2026-10-28 | superseded | 0.90 |
metric.venture.funding_recency_days | 43.3659 | derived | calc | 2026-10-28 | derived | 0.90 |
score.venture_signal | 55.2 | derived | calc | 2026-09-28 | superseded | 0.60 |
score.venture_signal | 55 | derived | calc | 2026-09-30 | superseded | 0.60 |
score.venture_signal | 54.9 | derived | calc | 2026-10-01 | superseded | 0.60 |
score.venture_signal | 54.3 | derived | calc | 2026-10-08 | superseded | 0.60 |
score.venture_signal | 54.2 | derived | calc | 2026-10-09 | superseded | 0.60 |
score.venture_signal | 54.1 | derived | calc | 2026-10-10 | superseded | 0.60 |
score.venture_signal | 54 | derived | calc | 2026-10-11 | superseded | 0.60 |
score.venture_signal | 53.9 | derived | calc | 2026-10-12 | superseded | 0.60 |
score.venture_signal | 53.8 | derived | calc | 2026-10-13 | superseded | 0.60 |
score.venture_signal | 53.7 | derived | calc | 2026-10-14 | superseded | 0.60 |
score.venture_signal | 53.6 | derived | calc | 2026-10-15 | superseded | 0.60 |
score.venture_signal | 53.5 | derived | calc | 2026-10-16 | superseded | 0.60 |
score.venture_signal | 53.4 | derived | calc | 2026-10-18 | superseded | 0.60 |
score.venture_signal | 53.3 | derived | calc | 2026-10-18 | superseded | 0.60 |
score.venture_signal | 53.2 | derived | calc | 2026-10-19 | superseded | 0.60 |
score.venture_signal | 53.1 | derived | calc | 2026-10-20 | superseded | 0.60 |
score.venture_signal | 53 | derived | calc | 2026-10-21 | superseded | 0.60 |
score.venture_signal | 52.9 | derived | calc | 2026-10-22 | superseded | 0.60 |
score.venture_signal | 52.8 | derived | calc | 2026-10-23 | superseded | 0.60 |
score.venture_signal | 52.7 | derived | calc | 2026-10-25 | superseded | 0.60 |
score.venture_signal | 52.6 | derived | calc | 2026-10-26 | superseded | 0.60 |
score.venture_signal | 52.5 | derived | calc | 2026-10-27 | superseded | 0.60 |
score.venture_signal | 52.4 | derived | calc | 2026-10-28 | derived | 0.60 |
sector | emerging | derived | calc | 2026-10-01 | normalized | 0.50 |